JP2025503607A - セルピンペプチドおよびその使用方法 - Google Patents
セルピンペプチドおよびその使用方法 Download PDFInfo
- Publication number
- JP2025503607A JP2025503607A JP2024540848A JP2024540848A JP2025503607A JP 2025503607 A JP2025503607 A JP 2025503607A JP 2024540848 A JP2024540848 A JP 2024540848A JP 2024540848 A JP2024540848 A JP 2024540848A JP 2025503607 A JP2025503607 A JP 2025503607A
- Authority
- JP
- Japan
- Prior art keywords
- serpin
- peptide
- disease
- condition
- serpin peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263266444P | 2022-01-05 | 2022-01-05 | |
| US63/266,444 | 2022-01-05 | ||
| PCT/US2022/082669 WO2023133078A2 (en) | 2022-01-05 | 2022-12-30 | Serpin peptides and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503607A true JP2025503607A (ja) | 2025-02-04 |
| JP2025503607A5 JP2025503607A5 (enExample) | 2025-06-02 |
Family
ID=87074167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024540848A Pending JP2025503607A (ja) | 2022-01-05 | 2022-12-30 | セルピンペプチドおよびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20250161419A1 (enExample) |
| EP (1) | EP4460322A4 (enExample) |
| JP (1) | JP2025503607A (enExample) |
| CN (1) | CN118804758A (enExample) |
| AU (1) | AU2022431253A1 (enExample) |
| CA (1) | CA3247129A1 (enExample) |
| IL (1) | IL314135A (enExample) |
| WO (1) | WO2023133078A2 (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113429455B (zh) * | 2015-08-28 | 2024-11-22 | 赛品制药有限责任公司 | 用于疾病治疗的方法 |
| US10821094B2 (en) * | 2016-01-13 | 2020-11-03 | Children's Hospital Medical Center | Compositions and methods for treating allergic inflammatory conditions |
| WO2019199634A1 (en) * | 2018-04-09 | 2019-10-17 | Yale University | Bifunctional small molecules to target the selective degradation of circulating proteins |
| US20240342293A1 (en) * | 2019-10-10 | 2024-10-17 | Yale University | Engineered antibodies as molecular degraders through cellular receptors |
| EP4054713A4 (en) * | 2019-11-04 | 2024-02-07 | Azitra, Inc. | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING SKIN DISEASES AND DISORDERS USING LEKTI |
| US11779630B2 (en) * | 2020-07-06 | 2023-10-10 | Serpin Pharma, Llc | Peptides and methods of using the same |
| EP4294392A4 (en) * | 2021-02-22 | 2025-06-25 | Yale University, Inc. | TARGETED BIFUNCTIONAL DEGRADING AGENTS AND METHODS OF USE THEREOF |
-
2022
- 2022-12-30 AU AU2022431253A patent/AU2022431253A1/en active Pending
- 2022-12-30 WO PCT/US2022/082669 patent/WO2023133078A2/en not_active Ceased
- 2022-12-30 US US18/726,945 patent/US20250161419A1/en active Pending
- 2022-12-30 JP JP2024540848A patent/JP2025503607A/ja active Pending
- 2022-12-30 CA CA3247129A patent/CA3247129A1/en active Pending
- 2022-12-30 EP EP22919262.0A patent/EP4460322A4/en active Pending
- 2022-12-30 CN CN202280092284.4A patent/CN118804758A/zh active Pending
- 2022-12-30 IL IL314135A patent/IL314135A/en unknown
-
2023
- 2023-07-13 US US18/148,942 patent/US20230406906A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4460322A4 (en) | 2026-02-25 |
| IL314135A (en) | 2024-09-01 |
| US20250161419A1 (en) | 2025-05-22 |
| WO2023133078A3 (en) | 2023-08-17 |
| WO2023133078A2 (en) | 2023-07-13 |
| EP4460322A2 (en) | 2024-11-13 |
| US20230406906A1 (en) | 2023-12-21 |
| CN118804758A (zh) | 2024-10-18 |
| AU2022431253A1 (en) | 2024-07-25 |
| CA3247129A1 (en) | 2023-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8158589B2 (en) | Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1) | |
| CA2795390C (en) | Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof | |
| EP3058074B1 (en) | Oral delivery of angiotensin converting enzyme 2 (ace2) or angiotensin-(1-7) bioencapsulated in plant cells | |
| US8734775B2 (en) | Chemokine derived peptides that bind with chemokine receptor CXCR3 and uses for chronic wound and angiogenesis inhibition treatments | |
| KR20150135242A (ko) | C1 에스터라제 억제제 결핍과 관련된 장애의 예방 및 치료를 위한 c1-inh 조성물 및 방법 | |
| US20210008177A1 (en) | Elapidae neurotoxin enhances opioid analgesic effect and inhibits opioid induced hyperalgesia and tolerance | |
| CN111184856B (zh) | 小分子多肽tp-7在制备治疗慢性肾脏病药物中的用途 | |
| US11779630B2 (en) | Peptides and methods of using the same | |
| JP5691049B2 (ja) | 血管新生誘導活性及び抗菌活性を有する新規ポリペプチド並びにその医薬用途 | |
| JP5750766B2 (ja) | 血管新生誘導活性及び抗菌活性を有するポリペプチドおよびそれを含有する創傷治療剤 | |
| US20190216901A1 (en) | Acth prophylactic treatment of renal disorders | |
| KR101622524B1 (ko) | 안정한 펙시가난 제제 | |
| AU2016317574A1 (en) | Compositions and methods for the treatment of neurodamage | |
| AU2016373364A1 (en) | Short synthetic peptide and uses thereof | |
| US20230406906A1 (en) | Serpin peptides and methods of using the same | |
| HK40118659A (zh) | Serpin肽及其使用方法 | |
| KR20230034167A (ko) | Kai1 폴리펩타이드를 포함하는 간 섬유화 억제용 약학 조성물 및 이의 용도 | |
| CN115279402A (zh) | 对ve-ptp磷酸酶的抑制保护肾免于缺血-再灌注损伤 | |
| CN115335079A (zh) | 基于外泌体递送nf-kb抑制剂的用途 | |
| US20250066452A1 (en) | Synthetic amphipathic helical peptides and treatment methods using synthetic amphipathic helical peptides | |
| HK40121727A (zh) | Serpin肽衍生物及其使用方法 | |
| KR20180120341A (ko) | 폐 섬유증의 예방 또는 치료용 약학적 조성물 | |
| KR102115557B1 (ko) | 폐 섬유증의 예방 또는 치료용 약학적 조성물 | |
| Xie et al. | Exogenous IL-33 mitigates inflammatory responses by suppressing the NF-Κb signaling pathway, promoting blood-spinal cord barrier repair and neural functional recovery | |
| EP4000627A1 (en) | Treatment of abdominal aortic aneurysm after its clinical manifestation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241004 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250523 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250523 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20260508 |